Synthesize Bio is pioneering the use of AI for generative genomics. Its first foundation model, Generate Expression Model-1 (GEM-1), is built on the world's most comprehensive annotated gene expression data. GEM-1 can generate gene expression data based on experimental design descriptions of future and even currently impossible experiments for scientific discovery and drug development. Founded by Fred Hutchinson Cancer Center scientists Rob Bradley and Jeff Leek, the company's platform provides the world's leading generative genomics RNA-seq data to power generative genomics and AI-native biopharma innovation.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
09/17/25	$10,000,000	Seed	AI2 Incubator Inner Loop Capital Madrona Venture Group Point Field Partners Sahsen Ventures	undisclosed